NCT05797441

Brief Summary

Patients who complete prolonged exposure and cognitive processing therapy, the treatments for posttraumatic stress disorder (PTSD) with the most empirical support, continue to express a need for mental health treatment. A therapist-assisted self-management program for patients who have completed one of these two treatments and achieved symptom improvement has the potential to meet patients' stated treatment needs, maintain or build upon their PTSD symptom reductions, increase their confidence in managing their symptoms, and reduce the number of mental health appointments that they need to attend. Further, reducing the number if mental health sessions attended by completers of these time and resource intensive psychotherapies will increase the likelihood that their implementation in regular-practice clinics will be maintained.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

8 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 4, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

October 16, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 23, 2026

Completed
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

2.4 years

First QC Date

March 21, 2023

Last Update Submit

April 2, 2026

Conditions

Keywords

Post Traumatic Stress DisordersPTSDSelf-Management

Outcome Measures

Primary Outcomes (4)

  • PTSD Checklist-5 (PCL-5)

    PTSD Symptom Severity - Self-Reported; Range = 0-80; higher scores = more severe symptoms

    12 weeks post treatment initiation

  • Veterans' Affairs Mental Health Service Utilization

    All encounters with a mental health stop code in the Veterans Health Administration; variable is a count of total encounters

    9 month period from treatment initiation to 9 months later

  • PTSD Checklist-5 (PCL-5)

    PTSD Symptom Severity - Self-Reported; Range = 0-80; higher scores = more severe symptoms

    24 weeks post treatment initiation

  • PTSD Checklist-5 (PCL-5)

    PTSD Symptom Severity - Self-Reported; Range = 0-80; higher scores = more severe symptoms

    40 weeks post treatment initiation

Other Outcomes (16)

  • Patient Health Questionnaire-9 (PHQ-9)

    12 weeks post treatment initiation

  • Client Satisfaction Questionnaire - 8 (CSQ-8)

    12 weeks post treatment initiation

  • Brief Inventory of Psychosocial Functioning (BIPF)

    12 weeks post treatment initiation

  • +13 more other outcomes

Study Arms (2)

EMPOWER

EXPERIMENTAL

The goals of EMPOWER are to increase patients' self-efficacy for managing their PTSD, enable the maintenance or building upon gains made in TFT through the continued application of TFT skills, and encourage engagement in meaningful life activities. The program includes a Veteran workbook and four planned therapist contacts over the twelve weeks following TFT completion. The intervention includes: self-monitoring of symptoms, continued practice of TFT skills, engagement in meaningful activities, goal setting, and therapist support.

Behavioral: EMPOWER

Treatment As Usual

ACTIVE COMPARATOR

The comparison condition will be TAU following completion of TFT. In the spirit of TAU, providers will not be restricted in the type or intensity of services offered. Depending on local clinic policy or norms, providers randomized to TFT may provide post-TFT treatment themselves or Veterans may be referred to other providers and/or back to the clinician who referred the Veteran to TFT. If providers would have typically discharged Veterans following TFT, that is also allowable.

Other: Treatment As Usual

Interventions

EMPOWERBEHAVIORAL

The goals of EMPOWER are to increase patients' self-efficacy for managing their PTSD, enable the maintenance or building upon gains made in TFT through the continued application of TFT skills, and encourage engagement in meaningful life activities. The program includes a Veteran workbook and four planned therapist contacts over the twelve weeks following TFT completion. The intervention includes: self-monitoring of symptoms, continued practice of TFT skills, engagement in meaningful activities, goal setting, and therapist support.

EMPOWER

The comparison condition will be TAU following completion of TFT. In the spirit of TAU, providers will not be restricted in the type or intensity of services offered. Depending on local clinic policy or norms, providers randomized to TFT may provide post-TFT treatment themselves or Veterans may be referred to other providers and/or back to the clinician who referred the Veteran to TFT. If providers would have typically discharged Veterans following TFT, that is also allowable.

Treatment As Usual

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients will be eligible to participate if they:
  • complete a course of individually-delivered TFT with a study therapist at a participating site
  • experience a clinically meaningful change in PTSD symptomology
  • at the time of enrollment (in either the TAU or EMPOWER arm), are not planning to initiate another weekly psychotherapy for PTSD for another mental or psychosocial condition within 3 months
  • are willing to receive to either arm
  • provide informed consent

You may not qualify if:

  • Patients will be excluded if they report suicidal ideation that requires clinical monitoring at baseline

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

VA Greater Los Angeles Healthcare System, Sepulveda, CA

Sepulveda, California, 91343, United States

Location

James A. Haley Veterans' Hospital, Tampa, FL

Tampa, Florida, 33612, United States

Location

Jesse Brown VA Medical Center, Chicago, IL

Chicago, Illinois, 60612, United States

Location

Edward Hines Jr. VA Hospital, Hines, IL

Hines, Illinois, 60141-3030, United States

Location

Minneapolis VA Health Care System, Minneapolis, MN

Minneapolis, Minnesota, 55417-2309, United States

Location

Durham VA Medical Center, Durham, NC

Durham, North Carolina, 27705-3875, United States

Location

Cincinnati VA Medical Center, Cincinnati, OH

Cincinnati, Ohio, 45220-2213, United States

Location

Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC

Columbia, South Carolina, 29209-1638, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Shannon M. Kehle-Forbes, PhD

    Minneapolis VA Health Care System, Minneapolis, MN

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Conducting a planning RCT in preparation for a fully powered trial using a parallel two-group pragmatic RCT design in which providers (n = 36) will be randomized at a 2:1 ratio to deliver either EMPOWER (n = 60) or TAU (n = 30) to veterans who have completed prolonged exposure or cognitive processing therapy.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2023

First Posted

April 4, 2023

Study Start

October 16, 2023

Primary Completion

March 23, 2026

Study Completion

March 23, 2026

Last Updated

April 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations